4.24

11.29% 0.43

Cervomed Inc (CRVO)

Overview News Price History Discussions Forecast Stock Split

Cervomed Inc stock is traded at $4.24, with a volume of 107.59M. It is up +11.29% in the last 24 hours and up +39.47% over the past month. CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Previous Close:

$3.81

Open:

$4.68

24h Volume:

107.59M

Relative Volume:

22.39

Market Cap:

$39.26M

Revenue:

$2.09M

Net Income/Loss:

$-30.04M

P/E Ratio:

-1.2972

EPS:

-3.2685

Net Cash Flow:

$-27.57M

1W Performance:

+73.77%

1M Performance:

+39.47%

6M Performance:

-46.33%

1Y Performance:

-39.34%

1-Day Range:

$3.84

$7.81

1-Week Range:

$2.37

$7.81

52-Week Range:

$2.13

$13.13

Cervomed Inc Stock (CRVO) Company Profile

Name

Cervomed Inc

Sector

Healthcare (1104)

Industry

Biotechnology (617)

Phone

(617) 744-4400

Address

20 PARK PLAZA, BOSTON

Employee

Twitter

Next Earnings Date

2026-05-18

Latest SEC Filings

CRVO's Discussions on Twitter

Compare CRVO vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CRVO Cervomed Inc	4.24	39.26M	2.09M	-30.04M	-27.57M	-3.2685
VRTX Vertex Pharmaceuticals Inc	451.63	114.63B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	609.94	63.95B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.72	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	278.09	37.13B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	162.99	34.65B	742.00K	-1.37B	-1.07B	-7.0731

Cervomed Inc Stock (CRVO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-18-25	Initiated	Cantor Fitzgerald	Overweight
Mar-13-25	Upgrade	Chardan Capital Markets	Neutral → Buy
Dec-17-24	Downgrade	H.C. Wainwright	Buy → Neutral
Dec-11-24	Downgrade	Chardan Capital Markets	Buy → Neutral
Dec-11-24	Downgrade	Morgan Stanley	Overweight → Underweight
Dec-10-24	Downgrade	D. Boral Capital	Buy → Hold
Dec-06-24	Initiated	ROTH MKM	Buy
Dec-05-24	Initiated	H.C. Wainwright	Buy
Sep-18-24	Initiated	Chardan Capital Markets	Buy
Jul-26-24	Initiated	Morgan Stanley	Overweight
Feb-15-24	Initiated	Canaccord Genuity	Buy
Nov-17-20	Downgrade	H.C. Wainwright	Buy → Neutral
Mar-21-18	Initiated	H.C. Wainwright	Buy

View All

Cervomed Inc Stock (CRVO) Latest News

Jun 19, 2026

Why did CRVO stock crash 22% in pre-market trading today? - MSN

Cervomed Inc (CRVO)

Cervomed Inc Stock (CRVO) Company Profile

Compare CRVO vs VRTX, REGN, ARGX, ALNY, RVMD

Cervomed Inc Stock (CRVO) Upgrades & Downgrades

Cervomed Inc Stock (CRVO) Latest News

Why did CRVO stock crash 22% in pre-market trading today? - MSN

CervoMed shares surge after securing US patent protection for dementia therapy (CRVO) - MSN

CRVO Stock Explodes As Insider Buying Fuels Biotech Momentum - timothysykes.com

CervoMed announces $10M registered direct offering priced at-the-market - TipRanks

CervoMed rises on patent news, pares gains after $10M equity sale - TechStock²

CRVO Stock Rockets Nearly 100% On Patent Win Before Offering News Cools Rally - Asianet Newsable

CervoMed Reports $10 Million Direct Offering of Shares - Moomoo

CervoMed prices $10M registered direct offering at $4/share - Investing.com

CervoMed prices $10M registered direct offering at $4/share By Investing.com - Investing.com South Africa

CervoMed Announces $10 Million Registered Direct Offering - GlobeNewswire

CervoMed sells 2.5 million shares at $4.00 each to raise $10M - Stock Titan

CervoMed Inc. Receives Patent Allowance for Neflamapimod in Lewy Body Dementia, Securing IP Protection Through 2042 – Minichart - Minichart

CervoMed Shares Surge After Securing U.S. Patent Protection for Dementia Therapy (CRVO) - Yahoo Finance

CRVO Stock Soars As Insider Buy And Cash Raise Extend Runway - StocksToTrade

CRVO Stock Explodes As Insider Buy Fuels Biotech Momentum - timothysykes.com

3 Stocks To Watch Today: CRVO, SPRO, QNRX - RTTNews

CervoMed stock jumps 20% on new U.S. patent allowance By Investing.com - Investing.com Nigeria

CervoMed stock jumps 20% on new U.S. patent allowance - Investing.com UK

CervoMed (CRVO) Secures Patent for Dementia Treatment Innovation - GuruFocus

CervoMed Gains New Patent for Neflamapimod Dementia Therapy - TipRanks

CervoMed Secures New U.S. Patent Protecting Use of Neflamapimod in Pure Dementia With Lewy Body Patients - marketscreener.com

CervoMed receives US patent allowance for neflamapimod use in Lewy body dementia By Investing.com - Investing.com Australia

CervoMed receives patent allowance for dementia treatment - Investing.com

CervoMed receives patent allowance for dementia treatment By Investing.com - Investing.com South Africa

CervoMed receives US patent allowance for neflamapimod use in Lewy body dementia - Investing.com

CervoMed (NASDAQ: CRVO) secures USPTO patent protection on neflamapimod to 2042 - Stock Titan

CervoMed Secures New U.S. Patent Protecting Use of Neflamapimod in Pure Dementia with Lewy Body Patients into 2042 - The Manila Times

CervoMed wins U.S. patent allowance for pure DLB treatment - Stock Titan

CervoMed secures U.S. patent for pure DLB treatment - grafa.com

CervoMed Inc (CRVO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

CervoMed Inc (CRVO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

CervoMed Inc (CRVO) Valuation: PE, PB & Fair Value Analysis - TradingKey

CervoMed Inc (CRVO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

CervoMed Inc (CRVO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

CervoMed Inc (CRVO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

CervoMed Inc (CRVO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

CervoMed Inc (CRVO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

CervoMed Stock (CRVO) Opinions on Recent Volatility Surge - Quiver Quantitative

Promising Penny Stocks To Watch In June 2026 - simplywall.st

Top Biotech Gainers: CRVO On Watch, SLP Scooped Up, LNAI Back In Compliance, NTHI Advances NEO212 - RTTNews

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

CervoMed (CRVO) Stock Soars 32% on $3 Million Director Purchase - parameter.io

CervoMed (CRVO) Surges 32% as Director Purchases $3 Million in Shares - Blockonomi

CervoMed (CRVO) Surges 32% Following Director’s $3 Million Stock Purchase - MoneyCheck

CervoMed (CRVO) Stock Jumps 32% After Director Buys $3M – Time to Buy? - CoinCentral

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

CRVO Stock Quote Price and Forecast - CNN

Cash from financing activities of CervoMed Inc. – DUS:DP8 - TradingView

CervoMed raises $10.5 million in private placement financing By Investing.com - Investing.com Nigeria

Long term debt to total equity ratio of CervoMed Inc. – DUS:DP8 - TradingView

CervoMed Inc. Statistics – DUS:DP8 - TradingView

Cervomed Inc Stock (CRVO) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to CRVO